Topiramate (Topamax) in Pregnancy: Risks and Safer Alternatives

Topiramate is contraindicated in pregnancy due to a well‑established risk of major congenital malformations, particularly orofacial clefts (cleft lip/palate). Data from pregnancy registries show a 2–5% cleft risk vs. 0.1% in the general population. Additional risks include low birth weight, growth restriction, and potential neurodevelopmental effects.

If you are pregnant or planning pregnancy, do not stop topiramate abruptly (seizure rebound risk). Consult your neurologist or psychiatrist immediately to transition to a safer alternative (e.g., lamotrigine, levetiracetam for epilepsy; other prophylactics for migraine). Folic acid supplementation (4 mg/day) is recommended before conception and throughout pregnancy for all women on antiseizure medications.

Pregnancy & Health - Related Articles